Multiparametric MRI detects more local recurrences after prostatectomy than prostate-specific membrane antigen PET-CT, with the two showing only moderate agreement.

The precise identification of tumor boundaries during radical prostatectomy remains a major clinical challenge. As positive ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

To our knowledge, this is the greatest survival benefit, based upon hazard ratio, ever seen in a prostate cancer,” said study presenter Stephen J. Freedland, MD.

Following the 2025 ESMO Congress, Dr. Joshua Saba sat down with Dr. Chandler Park to discuss recent advances in prostate cancer care.

A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring prostate cancer. This dual the ...

Data from the Colorado Central Cancer Registry shows Routt County had the highest rate of prostate cancer among all Colorado ...

Tom Nolan reviews this week’s research People with diabetes who have a minor acute ischaemic stroke are at high risk of having another stroke within three months. A small open label trial set in China ...

Houston couple Jesusa "Soozie" Cisneros and Tony Cisneros were diagnosed with separate types of cancer on the exact same day ...

A prostate cancer diagnosis and life during and after treatments can feel overwhelming. Alongside the shock of a diagnosis, you may be faced with ...

Trinidad and Tobago cannot afford a 10% salary increase for public servants, economist Prof Roger Hosein has warned.Hosein ...